News
New findings from the HERO Study show a 96% cure rate in hepatitis C retreatment among people who inject drugs. See what this means for HCV elimination goals.
Researchers evaluated the burden of hepatitis C virus infection among adult patients with HIV infection in the United States during the era of direct-acting antiviral therapy.
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...
The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...
By understanding the different types of hepatitis and taking preventive measures, you're not just protecting your liver, ...
An in-depth look at Hepatitis D, why it’s so severe, and how new therapies bring hope for better treatment and prevention.
More Australians die from hepatitis B-related illness each year. Now experts are pushing for universal screening for all adults.
From a public health point of view, there are no specific strategies for prevention of hepatitis E virus infection. Exposures ...
Learn about hepatitis C, how it spreads, possible symptoms, and important steps to protect yourself and others from this virus.
"China has a very important role in understanding and combating hepatitis ... treatment evolves, GSK is focusing on novel, short-course therapies that enable patients' bodies to manage the virus ...
A Phase 2 clinical trial finds that ALT flares are common in hepatitis D patients treated with pegylated interferon-alpha, but pose no safety risk, and may even signal better viral response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results